|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 403/12 | (2006.01) |
| C07D 403/12 | (2013.01) | ||
| C07D 401/14 | (2006.01) | ||
| C07D 413/14 | (2013.01) | ||
| C07D 413/14 | (2006.01) | ||
| C07D 413/12 | (2013.01) | ||
| C07D 413/12 | (2006.01) | ||
| C07D 213/69 | (2013.01) | ||
| C07D 307/60 | (2013.01) | ||
| C07D 213/69 | (2006.01) | ||
| C07D 307/60 | (2006.01) | ||
| C07D 401/14 | (2013.01) | ||
| A61K 31/4184 | (2006.01) | ||
| C07D 213/79 | (2013.01) | ||
| A61K 31/423 | (2006.01) | ||
| C07D 307/68 | (2013.01) | ||
| A61K 31/4427 | (2006.01) | ||
| C07D 403/14 | (2013.01) | ||
| A61K 31/497 | (2006.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61K 31/44 | (2006.01) | ||
| A61K 31/423 | (2013.01) | ||
| A61K 31/341 | (2006.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61K 31/496 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 31/16 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Number of the document | 3757099 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20178083.0 |
| Date of filing the European patent application | 2015-03-19 | |
| (97) | Date of publication of the European application | 2020-12-30 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201462068322 P | 2014-10-24 | US | |
| 201562101164 P | 2015-01-08 | US |
| (72) |
BASSAGANYA-RIERA, Josep , US
CARBO BARRIOS, Adria , US
GANDOUR, Richard , US
COOPER, Julian, D. , US
HONTECILLAS, Raquel , US
|
| (73) |
LANDOS BIOPHARMA, INC. ,
1800 Kraft Drive
Suite 216, Blacksburg, VA 24060,
US
|
| (54) | LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS |
| LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS |